Part of Inizio, market-leading commercialization platform, Inizio Ignite is the global advisory partner for health and life sciences. Guided by purpose, passion, and precision, our people collaborate with clients to ignite impact, accelerate performance, and deliver lasting change for patients. By uniting strategy, insights, and innovation with a unique depth and breadth of expertise, we drive transformation and shape the future of health.
As a consulting firm with deep expertise in both generative AI and business strategy, we support leading pharmaceutical companies in developing and deploying AI agents. Our specialized team—with strong industry knowledge—works end-to-end across clinical research analysis, manufacturing quality management, and HCP engagement to deliver real, scalable impact.
PharmaForceIQ is a real-time engagement platform built for life sciences, giving you an unfair advantage in engaging the right HCPs and patients. Our platform unites deep affinity data for 7M+ HCPs, streamlined optichannel execution across 75K+ sites/platforms, and live Rx-level reporting to maximize spend. We update targeting and deployment dynamically, so you never miss a moment that matters, and that has earned us a 100% client renewal rate. Experience the power of true agility: launch on the optimal mix for your audience, optimize campaigns mid-flight, sync with the field effectively, and prove impact fast.
IBM is a leading global hybrid cloud and AI, and business services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service.
Impiricus is the first and only AI-powered HCP Engagement Engine. Founded by a practicing physician and a senior pharmaceutical executive, Impiricus was created to transform how life sciences companies support physicians. We ethically connect HCPs to pharma resources, reduce go-to-market costs and accelerate patient access to the treatments they need.
With our unique access to the largest opted-in network of HCPs, their insights, and clinical expertise, we are the leading provider of AI technology and real-time channels that life science companies need to deliver clear, reliable, and evidence-based resources directly into the hands of HCPs.
Guided by a council of 2000+ trusted HCP advisors, we ensure every interaction is clinically meaningful, ethically grounded and leads to better patient care.
